Lethargic Depression Study

Completed · Phase 3

Conditions studied: Epilepsy, Major Depressive Disorder (MDD)

In brief

This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.

Key facts

Study ID

NCT00064467

Run by

GlaxoSmithKline

People needed

268

Starts

2003-06-01

Expected to finish

2005-05-01

Last updated by the study team

2017-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary diagnosis of MDD with current duration lasting 12 weeks but no greater than 2 years.
• Generally in good health.
• Subject must read and write at a level sufficient to provide written informed consent.

You may not qualify if…

• Current or past history of seizure disorder.
• Subject has a primary diagnosis or received treatment for panic disorder, obsessive compulsive disorder (OCD), post traumatic stress disorder (PTSD), acute stress disorder, Bipolar I or II disorder, schizophrenia, or other psychotic disorder.
• Currently using illicit drugs or other psychotropic drugs.
• Patient poses a current suicidal risk or has attempted suicide in the past 6 months.

Where it is running

• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — Sherman Oaks, California, United States
• GSK Investigational Site — Temecula, California, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Cromwell, Connecticut, United States
• GSK Investigational Site — Hamden, Connecticut, United States
• GSK Investigational Site — Middletown, Connecticut, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Marietta, Georgia, United States
• GSK Investigational Site — Oak Brook, Illinois, United States
• GSK Investigational Site — Cedar Rapids, Iowa, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — Farmington Hills, Michigan, United States
• GSK Investigational Site — Ridgeland, Mississippi, United States
• GSK Investigational Site — Moorestown, New Jersey, United States
• GSK Investigational Site — Albuquerque, New Mexico, United States
• GSK Investigational Site — Beachwood, Ohio, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Lincoln, Rhode Island, United States
• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Houston, Texas, United States
• GSK Investigational Site — Lake Jackson, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.